Effects of m3 muscarinic acetylcholine receptor on collagen type Ⅰ expression and associated mechanism in vascular smooth muscle cells

Zhouyang Jiao,Jing Wu,Chao Liu,Bing Wen,Guowei Fu,Xinling Du,Wenzeng Zhao
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2016.09.030
2016-01-01
Abstract:Objective To investigate the effects of m3 muscarinic acetylcholine receptor (M3R) on collagen type Ⅰ (COL-Ⅰ) expression and its related mechanisms.Methods In cultured vascular smooth muscle cells A7r5,Western blotting was used to examine the protein expression of COL-Ⅰ,extracellular signal regulated kinase 1 and 2 (ERK1/2),phosphorylated-ERK1/2 (p-ERK1/2) and transforming growth factor-β1 (TGF-β1).Results M3R agonist acetycholine (1.0 × 10-9,1.0 x 10-8,1.0 x 10-7 mol/L) up-regulated COL-Ⅰ expression in A7r5 (P < 0.05),and the effect could be attenuated by M3R selective antagonist 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP)(1.302±0.181 vs.1.892 ±0.292,P <0.05).Furthermore,the up-regulation of COL-Ⅰ expression by M3R appeared to be mediated by an upregulation in phosphorylation of ERK1/2 (1.764 ± 0.067 vs.1.115± 0.053,P < 0.05).In addition,M3R enhanced the TGF-β1 expression (1.894 ± 0.064 vs.0.972 ± 0.037,P < 0.05) and TGF-β1 antagonist SB431542 inhibited M3R-induced p-ERK1/2 up-regulation (1.121 ±0.059 vs.1.875 ± 0.078,P<0.05).Conclusion These results suggest that M3R promotes COL-I expression in A7r5 via TGF-β1-ERK1/2 signaling pathway.
What problem does this paper attempt to address?